Monopar Therapeutics Inc.MNPRNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+27.1%
5Y CAGR+27.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+27.1%/yr
vs +32.7%/yr prior
5Y CAGR
+27.1%/yr
Consistent
Acceleration
-5.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $21.62M | +33.8% |
| 2024 | $16.16M | +83.0% |
| 2023 | $8.83M | -16.2% |
| 2022 | $10.54M | +15.4% |
| 2021 | $9.13M | +40.2% |
| 2020 | $6.51M | +50.5% |
| 2019 | $4.32M | +27.1% |
| 2018 | $3.40M | -79.5% |
| 2017 | $16.60M | +1291.9% |
| 2016 | $1.19M | - |